Clinical Trial

An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis

Name: An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis — clinical trial record (NCT07052032)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of the study is to evaluate the safety and efficacy of CND261 in patients with seropositive rheumatoid arthritis.

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-17

notable Trial sites reduced: 6 -> 3 locations 2026-04-17

Trial Details

NCT Number	NCT07052032
Lead Sponsor	Candid Therapeutics
Conditions	Rheumatoid Arthritis
Enrollment	47 participants
Start Date	2025-06-16
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-16